← Back to AUPH

Aurinia Pharmaceuticals Inc - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Dec 2025Filed 26/02/2026Sep 2025Filed 26/02/2026Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Dec 2024Filed 26/02/2026Sep 2024Filed 26/02/2026
$83$78$77$73$70$62$60$68
$37$34$211$32$22$23$1.4$14
$0.28$0.25$1.53$0.23$0.16$0.16$0.01$0.10
134138136138143146

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.